Octagon Therapeutics, Inc. — Form D
Octagon Therapeutics, Inc. of PROVIDENCE, RI, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-12. The offering totals $12.4M, of which $11.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-02-12
- Form: D
- Accession: 0001756982-24-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.4M
- Amount sold: $11.0M
- Remaining: $1.4M
- Investors: 53
- Date of first sale: 2024-01-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-504975
Issuer
- Name: Octagon Therapeutics, Inc.
- CIK: 0001756982
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 225 DYER ST., PROVIDENCE, RI, 02903
- Phone: (857) 488-3417
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ronald Lennox | Director | Providence, RI |
| Thorne Sparkman | Director | East Greenwich, RI |
| Isaac Stoner | Director | Kingston, RI |
| Isaac Stoner | Executive Officer | Kingston, RI |
| Fred Ausubel | Director | Cambridge, MA |
| Fred Ausubel | Executive Officer | Cambridge, MA |
| Paul Goldenheim | Director | Allston, MA |
| Shen Yu | Director | Allston, MA |
| Shen Yu | Executive Officer | Allston, MA |
Other filings by this issuer (3)
More